ZMUni Compliance Centre

Last month, ZMUni Compliance Centre hosted a webinar focused on compliance requirements for special cosmetics in China. During the session, we introduced the basic definitions, regulatory pathways including registration and timelines for different product types, and shared typical enforcement cases involving non-compliant formulations.   One major concern was the potential criminal liability linked to the use of prohibited or unapproved cosmetic ingredients — a growing issue in recent years. These cases highlight the need for full compliance, not just in formulation, but also in labeling and documentation.   To manage these risks, companies must understand China's regulatory ingredient references. The Safety and

From July 1 to July 9, 2025, 4 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA).   The technical requirements for the 4 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Phytonadione Epoxide In recent years, the growing emphasis on efficacy-driven skincare has brought increased attention to vitamin-based ingredients in cosmetics. Traditional Vitamin K-1, however, is banned under China's Safety Technical Standards for Cosmetic due to its instability and allergenic potential. To address these issues, the notifier, Shandong Guangtongbao Pharmaceutical Co., Ltd., developed a structurally optimized derivative

In the first half of 2025, cosmetic regulations worldwide have evolved steadily. From mature markets in Europe and North America to emerging Asian economies, countries have made updates to ensure consumer safety, protect the environment, and advance industry development.    These changes affect product market access and consumer interests directly.   ZMUni Compliance Centre has summarized key regulatory updates from major markets, including the EU, US, Canada, South Korea and ASEAN.   Europe   EU updated Borderline Manual Manual with Vial and Ampoule Product Criteria: On January 24, 2025, the European Commission updated the Borderline Manual to clarify that products

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics within China and globally in June 2025, with an emphasis on updates in cosmetic ingredients, cosmetic management, among others.   China Cosmetic Regulatory Updates  New Cosmetics Ingredients (NCI) Notification   In June 2025, 14 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include: The technical requirements for the 14 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet

From June 21 to June 30, 2025, 4 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA).     The technical requirements for the 4 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   HYDROXYTYROSOL Hydroxytyrosol is a phenylethanol derivative and a phytochemical compound found in olive oil and olive leaves derived from the olive tree. It possesses good lipid and water solubility, along with strong antioxidant activity. According to CosIng, its manufacturing process is generally described as organic synthesis. It is classified as a skin conditioning agent

    On June 24, 2025, China National Institute for Food and Drug Control (NIFDC) released two guidelines for new cosmetic ingredients, including:   Guidelines for Research and Determination of Safe Use History of New Cosmetic Ingredients (Trial)   Applicable NCI notification situations: situation 3 & situation 4, referring to ingredients that can provide sufficient evidence of having been safely used in marketed cosmetics for more than three years.   Key Highlights:   If the marketed cosmetic is not manufactured by the NCI registrant or notifier, the source of information must be clarified and proper authorization obtained. Continuous sales of the

    On June 24, 2025, China National Medical Products Administration (NMPA) issued an important announcement regarding significant adjustments for the Inventory of Existing Cosmetic Ingredient in China (IECIC).   Detailed adjustments are as follows:   1. Introducing Two-tier Inventory System   List I includes revisions and improvements to the IECIC 2021. List II covers new cosmetic ingredients that have completed their three-year safety monitoring period and are now officially included in IECIC.   *Background: In accordance with the Cosmetics Supervision and Administration Regulation, cosmetic ingredients that have completed the three-year safety monitoring period after being registered or notified as new cosmetic ingredients—without any safety

  On June 24,2025, China's National Institutes for Food and Drug Control (NIFDC) has released nine draft cosmetic standards for public consultation. These include the General Principles for Physicochemical Testing Methods, among others, and aim to further improving the cosmetic technical standards. The public consultation period will remain open until July 15, 2025.   Detailed standards as follows:   General Principles for Physicochemical Testing Methods (Draft fot Comment) Determination of Cannabidiol (CBD) and Other 5 kinds of Components in Cosmetics (Draft fot Comment) Skin Sensitization: Local Lymph Node Assay: BrdU-Flow Cytometry Method（LLNA:BrdU-FCM）(Draft fot Comment) Toxicokinetics (Draft fot Comment) General Technical